Literature DB >> 25533802

CVD prevention in 2014: Advances in the prevention of cardiovascular disease.

Nizal Sarrafzadegan1, Carolyn Gotay2.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25533802     DOI: 10.1038/nrcardio.2014.209

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

2.  Low-risk diet and lifestyle habits in the primary prevention of myocardial infarction in men: a population-based prospective cohort study.

Authors:  Agneta Akesson; Susanna C Larsson; Andrea Discacciati; Alicja Wolk
Journal:  J Am Coll Cardiol       Date:  2014-09-30       Impact factor: 24.094

3.  Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial.

Authors:  Catriona Jennings; Kornelia Kotseva; Dirk De Bacquer; Arno Hoes; Jose de Velasco; Silvio Brusaferro; Alison Mead; Jennifer Jones; Serena Tonstad; David Wood
Journal:  Eur Heart J       Date:  2014-03-09       Impact factor: 29.983

Review 4.  Epidemiological studies of CHD and the evolution of preventive cardiology.

Authors:  Nathan D Wong
Journal:  Nat Rev Cardiol       Date:  2014-03-25       Impact factor: 32.419

5.  Relationships between fine particulate air pollution, cardiometabolic disorders, and cardiovascular mortality.

Authors:  C Arden Pope; Michelle C Turner; Richard T Burnett; Michael Jerrett; Susan M Gapstur; W Ryan Diver; Daniel Krewski; Robert D Brook
Journal:  Circ Res       Date:  2014-10-27       Impact factor: 17.367

6.  EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic high-risk patients in general practice: cross-sectional survey in 12 European countries.

Authors:  Kornelia Kotseva; David Wood; Guy De Backer; Dirk De Bacquer; Kalevi Pyörälä; Zeljko Reiner; Ulrich Keil
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2010-10

Review 7.  Future of polypill use for the prevention of cardiovascular disease and strokes.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  Am J Cardiol       Date:  2014-06-06       Impact factor: 2.778

8.  Polypill therapy, subclinical atherosclerosis, and cardiovascular events-implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Márcio Sommer Bittencourt; Michael J Blaha; Ron Blankstein; Matthew Budoff; Jose D Vargas; Roger S Blumenthal; Arthur S Agatston; Khurram Nasir
Journal:  J Am Coll Cardiol       Date:  2013-10-23       Impact factor: 24.094

9.  Guideline-directed low-density lipoprotein management in high-risk patients with ischemic stroke: findings from Get with the Guidelines-Stroke 2003 to 2012.

Authors:  Gustavo Saposnik; Gregg C Fonarow; Wenquin Pan; Li Liang; Adrian F Hernandez; Lee H Schwamm; Eric E Smith
Journal:  Stroke       Date:  2014-10-09       Impact factor: 7.914

Review 10.  Lifestyle interventions to reduce diabetes and cardiovascular disease risk among children.

Authors:  Dorothy J Van Buren; Tiffany L Tibbs
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

  10 in total
  4 in total

1.  The role of serum levels of microRNA-21 and matrix metalloproteinase-9 in patients with acute coronary syndrome.

Authors:  Faramarz Darabi; Mahmoud Aghaei; Ahmad Movahedian; Ali Pourmoghadas; Nizal Sarrafzadegan
Journal:  Mol Cell Biochem       Date:  2016-09-02       Impact factor: 3.396

2.  Association of serum microRNA-21 levels with Visfatin, inflammation, and acute coronary syndromes.

Authors:  Faramarz Darabi; Mahmoud Aghaei; Ahmad Movahedian; Armin Elahifar; Ali Pourmoghadas; Nizal Sarrafzadegan
Journal:  Heart Vessels       Date:  2016-10-26       Impact factor: 2.037

3.  The association between dairy product intake and cardiovascular disease mortality in Chinese adults.

Authors:  Mohammad Talaei; Woon-Puay Koh; Jian-Min Yuan; An Pan
Journal:  Eur J Nutr       Date:  2016-07-22       Impact factor: 5.614

Review 4.  Lymphocytic subsets play distinct roles in heart diseases.

Authors:  Jing Wang; Yi Duan; Joost Pg Sluijter; Junjie Xiao
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.